Report #2895731

Received May 7, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: CA
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	2	UNK	—

Symptoms (1)

Incomplete course of vaccination

Symptom narrative

received one dose of Engerix B vaccine in 2018; This non-serious case was reported by a consumer via sales rep and described the occurrence of incomplete course of vaccination in a patient who did not receive HBV (Engerix B adult) for prophylaxis. Previously administered products included Engerix B (received one dose in 2018). The patient did not receive the 2nd dose of Engerix B adult. The patient had incomplete course of vaccination (Verbatim: received one dose of Engerix B vaccine in 2018). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 28-APR-2026 The patient received one dose of Recombivax or Engerix B vaccine back in 2018, and they wanted to know what can be given now and if they can consider that as the first dose and when should be the next dose can be given.